HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oréal first half sales

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics revenue grew 4.1% like-for-like, or 3.5% on a reported basis, to $8.5 bil. (€1=$1.20) during the first half of 2005, French beauty company reports July 11. Sales of consumer products were up 4.1% like-for-like, or 3.7% on a reported basis, to $4.55 bil., led by the performance of L'Oréal Paris True Match and Maybelline New York Dream Matte Mousse foundations and L'Oréal Men Expert, firm says. Active cosmetics gained approximately 13% to $677.3 mil. on sales of Vichy and La-Roche Posay skin care brands. Luxury products grew 1.4% like-for-like to $1.97 bil., but were flat on a reported basis, boosted by sales of Armani Black Code fragrance for men and Armani Cosmetics, as well as Lancôme, Kiehl's and Biotherm products, according to L'Oréal. In North America, revenues were up 7.2% like-for-like, or 3.8% on a reported basis, to $2.17 bil., driven by consumer products including Garnier Fructis hair care...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel